To include your compound in the COVID-19 Resource Center, submit it here.
Final data from a double-blind, U.S. Phase II trial in 26 patients undergoing carbon dioxide laser skin
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury